Google DeepMind CEO Demis Hassabis: AI May End Disease and Usher in “Radical Abundance”

The article features an in-depth interview with Demis Hassabis, the Nobel Prize-winning co-founder and CEO of Google DeepMind, discussing the current and future impact of artificial intelligence. Hassabis describes rapid advancements toward artificial general intelligence (AGI), which could soon match or exceed human versatility and reasoning. DeepMind’s AI innovations, such as protein structure prediction, are already transforming drug discovery and may lead to the eradication of diseases and a future of “radical abundance.” However, Hassabis warns of significant risks, including misuse by bad actors and the challenge of aligning autonomous AI with human values, emphasizing the importance of robust safety measures and global cooperation on AI governance.

Read more